ALESSANDRA FERRAJOLI to Molecular Targeted Therapy
This is a "connection" page, showing publications ALESSANDRA FERRAJOLI has written about Molecular Targeted Therapy.
Connection Strength
0.086
-
The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia. Expert Rev Hematol. 2020 08; 13(8):885-894.
Score: 0.086
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.